Get in Touch with Us
For questions about our company, drug candidates, business development opportunities, or for general inquiries, please reach out to us at info@pieris.com.
In December 2024, Pieris Pharmaceuticals merged with Palvella Therapeutics, Inc. Palvella Therapeutics (Nasdaq: PVLA), is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies. For more information about the Company and updates, please visit www.palvellatx.com or follow us on LinkedIn.
Boston
Address
Pieris Pharmaceuticals, Inc.
225 Franklin St., Floor 26
Boston, MA 02110
USA
+1-857-246-8998
Munich
Address
Pieris Pharmaceuticals GmbH
Carl-Zeiss-Ring 15a
85737 Ismaning
+49 89 – 26 20 22 940